Poly(3-guanidinopropyl methacrylate): A Novel Cationic Polymer for Gene Delivery
- 23 October 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 15 (6) , 1212-1220
- https://doi.org/10.1021/bc049864q
Abstract
A cationic polymethacrylate with a guanidinium side group was designed in order to create a polymer with cell membrane-penetrating properties such as Tat or other arginine-rich peptides. The polymer, poly(3-guanidinopropyl methacrylate), abbreviated as pGuaMA, was synthesized by free radical polymerization. The DNA-condensing properties of pGuaMA (Mw 180 kDa) were investigated via dynamic light scattering and zeta potential measurements, and small, positively charged particles (110 nm, +37 mV) were found. It was shown that polyplexes based on pGuaMA were able to transfect COS-7 cells efficiently in the absence of serum, while under the same conditions poly(arginine) (pArg) polyplexes did not show detectable transfection levels. Addition of a membrane-disrupting peptide, INF 7, derived from the influenza virus, to preformed pGuaMA polyplexes did result in ∼2 times increased transfection levels. DLS, zeta potential measurements, gel electrophoresis, and ethidium bromide displacement measurements indicated that serum induced aggregation of the polyplexes at high polymer/plasmid ratios, while at low polymer/plasmid ratios the polarity of the polyplexes reversed likely due to adsorption of negatively charged proteins on their surface. Likely, the unfavorable interactions of pGuaMA polyplexes with serum proteins is the reason for the absent transfection activity of these polyplexes in the presence of serum. Confocal laser scanning microscopy indicated cellular internalization via endocytosis of both polyplexes and free polymer. Thus, pGuaMA polyplexes enter cells, as reported for other polyplexes, by endocytosis and not, as hypothesized, via direct membrane passage.Keywords
This publication has 23 references indexed in Scilit:
- Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer?Pharmaceutical Research, 2004
- Extracellular and intracellular barriers in non-viral gene deliveryJournal of Controlled Release, 2003
- Tat-Conjugated Synthetic Macromolecules Facilitate Cytoplasmic Drug Delivery To Human Ovarian Carcinoma CellsBioconjugate Chemistry, 2002
- Prospects for cationic polymers in gene and oligonucleotide therapy against cancerAdvanced Drug Delivery Reviews, 2002
- Conjugates of Antisense Oligonucleotides with the Tat and Antennapedia Cell-Penetrating Peptides: Effects on Cellular Uptake, Binding to Target Sequences, and Biologic ActionsPharmaceutical Research, 2002
- Gene delivery with synthetic (non viral) carriersInternational Journal of Pharmaceutics, 2001
- Recent progress in gene delivery using non-viral transfer complexesJournal of Controlled Release, 2001
- A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell NucleusJournal of Biological Chemistry, 1997
- Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independentJournal of Biological Chemistry, 1996
- Cellular and Molecular Barriers to Gene Transfer by a Cationic LipidJournal of Biological Chemistry, 1995